Patents by Inventor Stephen Price

Stephen Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090195776
    Abstract: A method for collecting and analyzing spectrum data to identify a composition of a sample material is described. The method includes obtaining a sample material, receiving a geographical location of the sample material at a handheld instrument, and analyzing the sample material to obtain sample spectrum data using the handheld instrument. The method also includes determining whether to perform an analysis of the sample spectrum data using the handheld instrument, or to perform the analysis of the sample spectrum data using a remote computer. The method also includes determining a composition of the sample material based on an analysis of the sample spectrum data and recording in a memory area at least one of the composition and the geographical location of the sample material.
    Type: Application
    Filed: July 17, 2008
    Publication date: August 6, 2009
    Inventors: Roger David Durst, John Hooper Landefeld, Jeremy Lea, Larry Stephen Price
  • Patent number: 7489811
    Abstract: An optical inspection system is for visually inspecting the blades of a turbine at turning gear operation. The inspection system includes an imager for capturing images of the blades, an optical passage coupled to the imager and structured to provide maximum viewing area of the blades through an inspection port in the turbine and an illuminating assembly adapted to illuminate the blades while the imager captures images thereof. A method wherein the captured blade images are inspected for blade defects, is also disclosed.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: February 10, 2009
    Assignee: Siemens Energy, Inc.
    Inventors: Hans-Gerd Johann Brummel, William Alexander Landi, Dennis Lemieux, Michael Twerdochlib, Stephen Price Masticola
  • Publication number: 20090012082
    Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.
    Type: Application
    Filed: November 3, 2005
    Publication date: January 8, 2009
    Applicant: CURIS, INC.
    Inventors: Olivin M. Guicherit, Edward Andrew Boyd, Judith Boyd, Shirley Ann Brunton, Stephen Price, John Harry Alexander Stibbard, Colin H. MacKinnon
  • Patent number: 7443951
    Abstract: An x-ray fluorescence (XRF) device and a method for using the same to analyze a sample are described. The EMRXG source of the XRF device has a configuration that allows a greater amount of EMRXG to impinge on the sample being analyzed. The x-ray detector of the XRF device has a configuration that allows a greater amount of x-rays emitted by the sample to impinge on the detector. With such a configuration, the size and cost of the x-ray fluorescence device decreases. As well, fewer EMRXG are needed from the EMRXG source because of the greater efficiency and an exempt EMRXG source that is exempt from radioactivity licensing requirements can be used.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: October 28, 2008
    Assignee: KeyMasters Technologies, Inc.
    Inventors: Donald K. Kenning, L. Stephen Price, Bruce J. Kaiser
  • Publication number: 20080242655
    Abstract: The invention relates to azaindolyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azaindolyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
    Type: Application
    Filed: November 29, 2007
    Publication date: October 2, 2008
    Inventors: Simon Charles Goodacre, Karen Williams, Stephen Price, Hazel Joan Dyke, John Gary Montana, Mark S. Stanley, Liang Bao, Wendy Lee
  • Publication number: 20080207740
    Abstract: The present invention makes available methods and reagents for modulating proliferation or differentiation in a cell or tissue comprising contacting the cell with a hedgehog agonist, such as the compounds depicted in FIGS. 32 and 33. In certain embodiments, the methods and reagents may be employed to correct or inhibit an aberrant or unwanted growth state, e.g., by antagonizing a normal ptc pathway or agonizing smoothened or hedgehog activity.
    Type: Application
    Filed: August 20, 2007
    Publication date: August 28, 2008
    Applicant: Curis, Inc.
    Inventors: Anthony David Baxter, Edward Andrew Boyd, Maria Frank-Kamenetsky, Oivin Guicherit, Jeffery Porter, Stephen Price, Lee Rubin, John Harry Alexander Stibbard
  • Patent number: 7414067
    Abstract: This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: August 19, 2008
    Assignees: Merck & Co. Inc., Evotec OAI
    Inventors: Edward Andrew Boyd, Michael H. Fisher, Maria L. Garcia, Gregory J. Kaczorowski, Peter T. Meinke, William H. Parsons, Stephen Price, John Stibbard
  • Publication number: 20080192889
    Abstract: A handheld X-ray fluorescence (XRF) spectrometer is described. The handheld XRF spectrometer comprises a radiation source, a silicon drift detector (SDD), a cooling device configured to regulate the temperature of the SDD, at least one signal processing and power control module coupled to at least one of the radiation source, the SDD, and the cooling device, and a housing substantially encasing the radiation source, the SDD, the cooling device, and the at least one signal processing and power control module. The at least one signal processing and power control module includes at least one input/output connector.
    Type: Application
    Filed: February 14, 2008
    Publication date: August 14, 2008
    Inventors: Martin Rohde, Larry Stephen Price, Vassili Kobyitchak
  • Publication number: 20080085886
    Abstract: The invention relates to azabenzofuranyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzofuranyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
    Type: Application
    Filed: August 20, 2007
    Publication date: April 10, 2008
    Inventors: Pascal Savy, Stephen Price, Hazel Dyke, John Montana, Karen Williams, Mark Stanley, Liang Bao
  • Publication number: 20080081821
    Abstract: The invention relates to azabenzothiophenyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzothiophenyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
    Type: Application
    Filed: August 20, 2007
    Publication date: April 3, 2008
    Inventors: Pascal Savy, Stephen Price, Hazel Dyke, John Montana, Karen Williams, Mark Stanley, Liang Bao
  • Publication number: 20080004282
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: April 10, 2007
    Publication date: January 3, 2008
    Applicant: PainCeptor Pharma Corporation
    Inventors: Rahul Vohra, Zhonghong Gan, Chang-Qing Wei, Stephen Price, Hazel Dyke, Elsa Dechaux
  • Publication number: 20080004306
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: April 10, 2007
    Publication date: January 3, 2008
    Applicant: PainCeptor Pharma Corporation
    Inventors: Rahul Vohra, Zhonghong Gan, Hazel Dyke, Stephen Price
  • Publication number: 20070283675
    Abstract: One or more elongate barriers are provided that are movably (in one configuration pivotably) mounted proximate the outside of a grass cutting deck. When one of the barriers encounters a foreign object in a certain manner, the barrier moves towards its “tripped” position, thus causing a corresponding change to the operating characteristic of the lawn mover, be it a termination of the cutting process, the mower drive process, or both. The barriers can be used with electric or mechanical control elements.
    Type: Application
    Filed: May 3, 2007
    Publication date: December 13, 2007
    Applicant: SNAPPER, INC.
    Inventors: Frank Hancock, Stephen Price
  • Publication number: 20070273550
    Abstract: A Smart Ceiling Tile and Method of Using is disclosed in various versions of the invention. One version is a system for a ceiling sign, comprising a means for suspending from or connecting to a ceiling at least one horizontal or nearly horizontal frame of suitable width, length and height, and at least one ceiling tile of suitable width, length and height, disposed on or in the frame, and the ceiling tile having means for conveying information to one of the senses. Another version is a process of using a ceiling tile, said process comprising the steps of: (a) suspending at least one horizontal or nearly horizontal frame from a ceiling; (b) disposing on or in the frame at least one ceiling tile further comprising a pre-determined configuration of means for conveying information to one of the senses; (c) allowing the means for conveying information to one of the senses to communicate with one of the senses of a user.
    Type: Application
    Filed: May 25, 2007
    Publication date: November 29, 2007
    Inventors: Marcus Stephen Price, M. J. Vassar Price, Robert John Stephens
  • Patent number: 7300929
    Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: November 27, 2007
    Assignee: Curis, Inc.
    Inventors: Anthony David Baxter, Edward Andrew Boyd, Oivin Guicherit, Stephen Price, Lee L. Rubin
  • Publication number: 20070249648
    Abstract: The invention provides compounds of general formula. wherein A, B, W, X, Y, Z, D, E, R1 and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: October 21, 2004
    Publication date: October 25, 2007
    Inventors: Håkan Bladh, Stephen Connolly, Hazel Dyke, Annea Lisius, Stephen Price, Igor Shamovsky, Marco Van Den Heuvel
  • Publication number: 20070097399
    Abstract: A print controller, methods, and software are disclosed. A print controller of the invention includes applications, a parameter manager, and a notification system. The applications register with parameter manager those parameters for which they want to be notified when a change occurs. As part of the registration, the applications designate a callback identifier (CID) for each of the parameters, where an individual CID may be associated with a single parameter or a plurality of related parameters. Responsive to receiving an indication of changes to one or more of the parameters, the notification system identifies the applications registered to be notified of changes to the parameters, and identifies the CIDs associated with the parameters that have changed. The notification system then transmits one or more notification messages, including the identified CIDs for the changed parameters, to each application that is registered.
    Type: Application
    Filed: October 28, 2005
    Publication date: May 3, 2007
    Inventors: Erin Boyd, Samuel Hopper, Kent Norgren, Stephen Price
  • Publication number: 20060287385
    Abstract: The present invention makes available methods and reagents for modulating proliferation or differentiation in a cell or tissue comprising contacting the cell with a hedgehog agonist, such as the compounds depicted in FIGS. 32 and 33. In certain embodiments, the methods and reagents may be employed to correct or inhibit an aberrant or unwanted growth state, e.g., by antagonizing a normal ptc pathway or agonizing smoothened or hedgehog activity.
    Type: Application
    Filed: April 27, 2006
    Publication date: December 21, 2006
    Inventors: Anthony Baxter, Edward Boyd, Maria Frank-Kamenetsky, Oivin Guicherit, Jeffery Porter, Stephen Price, Lee Rubin, John Stibbard
  • Patent number: 7115653
    Abstract: The present invention makes available methods and reagents for modulating proliferation or differentiation in a cell or tissue comprising contacting the cell with a hedgehog agonist, such as the compounds depicted in FIGS. 32 and 33. In certain embodiments, the methods and reagents may be employed to correct or inhibit an aberrant or unwanted growth state, e.g., by antagonizing a normal ptc pathway or agonizing smoothened or hedgehog activity.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: October 3, 2006
    Assignee: Curis, Inc.
    Inventors: Anthony David Baxter, Edward Andrew Boyd, Maria Frank-Kamenetsky, Oivin Guicherit, Jeffery Porter, Stephen Price, Lee L. Rubin, John Harry Alexander Stibbard
  • Publication number: 20060193453
    Abstract: A telephone call screening system screens telephone calls placed to a subscriber based upon a preferred caller database established by the subscriber from a networked caller registry database. A caller registration system allows callers to select a private identifier unique to the caller and registers the callers in a caller registry database. The subscriber establishes the preferred caller database by connecting to the caller registration system and selecting the preferred callers. The private identifiers associated with the selected preferred callers are then stored in the preferred caller database. When a caller calls the subscriber, the caller is asked to enter the caller's private identifier. A caller disposition process is initiated based on whether the private identifier is in the preferred caller database.
    Type: Application
    Filed: April 11, 2006
    Publication date: August 31, 2006
    Applicant: Prologue Communications, Inc.
    Inventor: Stephen Price